<DOC>
	<DOC>NCT00120211</DOC>
	<brief_summary>This trial compares the use of 6 fractions versus the standard 5 fractions of radiotherapy used in the treatment of head and neck cancer.</brief_summary>
	<brief_title>Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer</brief_title>
	<detailed_description>The purpose of this trial is to study the clinical effects of increasing the weekly fraction number for locally advanced head and neck cancers by a multi-institutional prospective randomised trial. The primary endpoint is to clarify whether a six fraction per week protocol has a greater effect on the survival, as compared to the conventional five fraction per week protocol.</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Head and Neck Cancer Unable to give an informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>